Department of Pharmacology and Therapeutics, McGill University, Montréal, Canada.
Mini Rev Med Chem. 2012 Aug;12(9):817-30. doi: 10.2174/138955712800959143.
The great versatility of G protein-coupled receptors (GPCRs), in terms of both their ability to bind different types of ligands and initiate a large number of distinct cellular signaling events, remains incompletely understood. In recent years, the classical view of the nature and consequences of ligand binding to GPCRs has dramatically changed. The notion of functional selectivity, achieved through both biased ligands and allosteric modulators, has brought substantial new insight into our comprehension of the pluridimensionality of signaling achieved by GPCRs. Moreover, receptor heterodimerization adds another important dimension to the diversity of cellular responses controlled by GPCRs. Here, we review these considerations and discuss how they will impact the design of improved therapeutics.
G 蛋白偶联受体 (GPCRs) 的多功能性,无论是在结合不同类型配体的能力还是在引发大量不同的细胞信号事件的能力方面,都还不完全清楚。近年来,对配体与 GPCRs 结合的性质和后果的经典观点发生了巨大变化。通过偏倚配体和变构调节剂实现的功能选择性的概念,为我们理解 GPCRs 实现的信号转导的多维性提供了实质性的新见解。此外,受体异二聚化为 GPCRs 控制的细胞反应多样性增加了另一个重要维度。在这里,我们回顾了这些考虑因素,并讨论了它们将如何影响改进治疗方法的设计。